Hollie Lai

Phase I Study of the Aurora A Kinase Inhibitor Alisertib in Combination With Irinotecan and Temozolomide for Patients With Relapsed or Refractory Neuroblastoma: A NANT (New Approaches to Neuroblastoma Therapy) Trial

Steven G. DuBois, Araz Marachelian, Elizabeth Fox et al. · Journal of Clinical Oncology · 2016 · 132 citations

2024 Update of the North American Consensus Guidelines for Pediatric Administered Radiopharmaceutical Activities

S. Ted Treves, Frederic H. Fahey, Valentina Ferrer Valencia et al. · Journal of Nuclear Medicine Technology · 2025 · 96 citations

A Phase I New Approaches to Neuroblastoma Therapy Study of Buthionine Sulfoximine and Melphalan With Autologous Stem Cells for Recurrent/Refractory High-Risk Neuroblastoma

Judith G. Villablanca, Samuel L. Volchenboum, Hwangeui Cho et al. · Pediatric Blood & Cancer · 2016 · 91 citations · Full text

Phase II Trial of Alisertib in Combination with Irinotecan and Temozolomide for Patients with Relapsed or Refractory Neuroblastoma

Steven G. DuBois, Yaël P. Mossé, Elizabeth Fox et al. · Clinical Cancer Research · 2018 · 86 citations

MRI Radiogenomics of Pediatric Medulloblastoma: A Multicenter Study

Michael Zhang, Samuel W Wong, Jason N. Wright et al. · Radiology · 2022 · 72 citations · Full text